Crossbow Therapeutics, Inc
Preethi Sankaran is a scientist with extensive experience in biomedical research and biotechnology. Currently working as a Scientist I at Crossbow Therapeutics, Inc. since November 2022, Preethi previously held the role of Senior Research Associate at Rubius Therapeutics, where diverse cell health assays were optimized for Red Cell Therapeutics and significant contributions to pharmacokinetic studies were made. Earlier experiences include a Research Technologist position at The Johns Hopkins University School of Medicine, where Preethi managed human cancer clinical trial bio-specimens and engaged in various analytical techniques. Additionally, Preethi has held roles at Teneobio, Natera, and the University of Pittsburgh, accumulating skills in antibody characterization, clinical sample processing, and research methodologies. Preethi earned a Master of Science in Biotechnology and an MBA from The Johns Hopkins University, along with a Bachelor's in Biology from the University of Pittsburgh.
Crossbow Therapeutics, Inc
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.